BTIG analyst Maria Thibault revised the price target for Outset Medical (TASE:PMCN) Inc. (NASDAQ:OM) to $3.00, a decrease ...
Outset Medical is set to present at the prestigious 43rd annual J.P. Morgan Healthcare conference, which could enhance visibility and credibility within the healthcare sector. The company's ...
Ahmed Nabeel, the Chief Financial Officer of Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), recently reported a series of stock transactions in a filing with the Securities and Exchange Commission.
RBC Capital Mkts has recently reduced Outset Medical Inc (OM) stock to Sector Perform rating, as announced on August 8, 2024, according to Finviz. Earlier, on June 21, 2024, RBC Capital Mkts had ...
Outset Medical has announced a $169 million private placement financing and a new debt facility of up to $125 million, aiming to retire prior debt and bolster its financial position. This ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...
Outset Medical's financial trajectory has shown signs of improvement, despite facing challenges. In its Q3 2024 earnings report, the company surpassed expectations and subsequently raised its 2024 ...
Short interest in Outset Medical Inc (NASDAQ:OM) decreased during the last reporting period, falling from 2.80M to 2.62M. This put 5.83% of the company's publicly available shares short.
Outset Medical, Inc. SAN JOSE, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to ...